SciClone Hit With Second Federal FCPA Securities Suit
The Hong Kong-based drugmaker said in an August regulatory filing that it was under investigation for potential Foreign Corrupt Practices Act violations.
To read more
Subscribe to Global Investigations Review
Subscribe and start reading now
Global Investigations Review (GIR) is the hub for global coverage of corporate investigations and their aftermath. Keep up to date with significant developments in the corporate investigations world.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10